For the year ending 2025-12-31, BDTX has $143,010K in assets. $30,799K in debts. $20,990K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 20,990 | |||
| Investments | 107,662 | |||
| Prepaid expenses and other current assets | 3,788 | |||
| Total current assets | 132,440 | |||
| Property and equipment, net | 365 | |||
| Restricted cash | 829 | |||
| Right-of-use assets | 9,303 | |||
| Other non-current assets | 73 | |||
| Total assets | 143,010 | |||
| Accounts payable | 579 | |||
| Accrued expenses and other current liabilities | 15,152 | |||
| Total current liabilities | 15,731 | |||
| Non-current operating lease liability | 15,068 | |||
| Total liabilities | 30,799 | |||
| Common stock 0.0001 par value 500,000,000 shares authorized at december31, 2025 and 500,000,000 shares authorized at december31, 2024 57,138,057 shares issued and outstanding at december31, 2025 and 56,644,655 shares issued and outstanding at december31, 2024 | 8 | |||
| Additional paid-in capital | 576,842 | |||
| Accumulated other comprehensive income (loss) | 101 | |||
| Accumulated deficit | -464,740 | |||
| Total stockholders' equity | 112,211 | |||
| Total liabilities and stockholders' equity | 143,010 | |||
Black Diamond Therapeutics, Inc. (BDTX)
Black Diamond Therapeutics, Inc. (BDTX)